Seeking Alpha

  Arrowhead Research Corporation (ARWR) - NASDAQ

  • World Market Media | Send Message 8 Jun 2010

    Arrowhead Research Corporation (NASDAQ: ARWR) $107M (MarketCap) Receives Grant from the State of Texas
      ARWR vs. ETF Alternatives
      Company Description
      Arrowhead Research Corp is engaged in developing novel drugs to treat intractable diseases by silencing the genes. The Company's drug candidate ARC-520 is designed to treat chronic hepatitis B infection.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States